Polaris Innovation Fund is a Boston-based venture capital fund within Polaris that focuses on accelerating the commercial and therapeutic potential of early-stage academic research. It backs early-stage biotechnology, life sciences and healthcare companies in the United States, with emphasis on molecules and platforms, therapeutics, genomics, pharmaceuticals and oncology-related opportunities.